Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Lexaria Bioscience Corp. (LEXX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-02-28.
| Income Statement Financials | |
$0.02M |
|
$-1.45M |
|
-- |
|
$0.02M |
|
$1.47M |
|
$-1.45M |
|
$0.00M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.45M |
|
$-1.43M |
|
24.44M |
|
24.44M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$5.77M |
|
$0.24M |
|
$0.72M |
|
$6.49M |
|
$0.21M |
|
-- |
|
$0.06M |
|
$0.28M |
|
$6.21M |
|
$5.89M |
|
$6.21M |
|
24.89M |
|
| Cash Flow Statement Financials | |
$-3.15M |
|
$-0.06M |
|
$6.52M |
|
$1.80M |
|
$5.13M |
|
$3.33M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.88 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-7259.52% |
|
-7259.52% |
|
-- |
|
-7250.67% |
|
-7249.90% |
|
$-3.19M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.48 |
|
189.13 |
|
-23.39% |
|
-24.66% |
|
-22.39% |
|
-23.39% |
|
$0.25 |
|
$-0.13 |
|
$-0.13 |
|